Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
eNq1mFFv2jAQx9/5FFHeSUiB0k6BamNlQ2pVRos27QWZ5ChmwU7PNqX79HMI3ejkqK3Bj/E5/zv7zj+fHF9sVpm3BhSUs64fBQ3fA5bwlLL7rj+5G9TP/IteLV6SNdmb1gkaQXTie0lGhOj6hTWYAWEi+HF99Rn0/4B+r+bFfLaERL6YpyTNgq9ELK5JXszx4jWnqbcCueBp18+V3I56sZCoo+g9cvwlcpJAHO5G9q3LaWt/PA4LsTeoKgF4Rdi9URSYlWaiEIHJPpFwz/GpIt6mlTYVYxBcYQIjIhcj5GuaQmp0MSeZACsn88f0FnCdgSycGMXDZbISVuJkSTZjeBiag/6orX25kfVGPep02lEjarU6p0275OLeVpmzoBcRJtOo2T7vNBshMK2sLTp5lskZcZQkc5QWKvovK8uRH4SHV9OfUpFn5ClYitx2qwgSbQbU59/dQooV3KEmUqb37D99prIsfGfUkx0vHEVc4KjPFZMV2BiMbTeiz5mETXVG7UgnN7tapCCOJ/ubMzPlR2qW0cSWaZo6CoScjIfVSDsqDT4RARN0h4PvlKX8URwfM/tpdRR9viWlUTTHNJqenJ+dRu229Sn6qWuo4o65VMhzCDWAqDiEK0M254cSRZelWeq5KI9Xj9tWhyckg4pmp25JF12Iz72Zs1J3d4xKg1H0y+WdbX18U4BPt9tPozRNu38za4deFzzX1VgZ+PtruzziTtpghWZ0LKTMxYcwXBBRF0TvUDDH43N97y5114E7ubDLBqZko6PQZ+Wl9/b02B6x167zQ1vU3f+7VtjoQ6KCA/JQ0tgZM4eXx8fwv/7UWdijF9hw52bbSxJJOXPV4qiZUfEw8Ou8sgFqONzM57TiNaSyLuOwfInp1eKweIXp1f4A7wDjtg==
vGbSs5Ka4Hxzg45z
